Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-27T14:56:56.962Z Has data issue: false hasContentIssue false

Chapter 11 - Neuromuscular Disease

Published online by Cambridge University Press:  14 March 2018

By
Enjarn Lin  and
Stuart Hastings
Edited by
A. Agatha Crerar-Gilbert  and
Mark MacGregor
A. Agatha Crerar-Gilbert
Affiliation:
St George's Hospital, London
Mark MacGregor
Affiliation:
Ashford and St Peter’s Hospital Trust
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Core Topics in Preoperative Anaesthetic Assessment and Management , pp. 139 - 154
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alshekhlee, A. et al., 2009. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology, 72(18), 1548–54.CrossRefGoogle ScholarPubMed
Arnold, W. D., Kassar, D. & Kissel, J. T., 2014. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle & Nerve, 51(2), 157–67.Google Scholar
Bandschapp, O. & Iaizzo, P. A., 2013. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses. Paediatric Anaesthesia, 23(9), 824–33.CrossRefGoogle ScholarPubMed
Banerjee, A. et al., 2013. PABPN1: molecular function and muscle disease. The FEBS Journal, 280(17), 4230–50.CrossRefGoogle ScholarPubMed
Birnkrant, D. J. et al., 2007. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest, 132(6), 1977–86.CrossRefGoogle ScholarPubMed
Brady, J. E. et al., 2009. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005. Anesthesia and Analgesia, 109(4), 1162–6.CrossRefGoogle ScholarPubMed
Bushby, K. et al., 2010. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet.CrossRefGoogle Scholar
Chinnery, P. F. & Turnbull, D. M., 2001. Epidemiology and treatment of mitochondrial disorders. American Journal of Medical Genetics, 106(1), 94–101.CrossRefGoogle ScholarPubMed
Chiò, A. et al., 2003. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology, 60(7), 1146–50.CrossRefGoogle ScholarPubMed
Compston, A. & Coles, A., 2008. Multiple sclerosis. Lancet, 372(9648), 1502–17.CrossRefGoogle ScholarPubMed
DiMauro, S. & Schon, E. A., 2003. Mitochondrial respiratory-chain diseases. New England Journal of Medicine, 348(26), 2656–68.CrossRefGoogle ScholarPubMed
Driessen, J. J., 2008. Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist? Current Opinion in Anaesthesiology, 21(3), 350–5.CrossRefGoogle Scholar
Dürr, A. et al., 1996. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. New England Journal of Medicine, 335(16), 1169–75.CrossRefGoogle ScholarPubMed
Ekins, S. et al., 2015. A brief review of recent Charcot-Marie-Tooth research and priorities. F1000Research.CrossRefGoogle Scholar
Fiszer, D. et al., 2015. Next-generation sequencing of RYR1 and CACNA1S in malignant hyperthermia and exertional heat illness. Anesthesiology.CrossRefGoogle Scholar
Flanigan, K. M., 2014. Duchenne and Becker muscular dystrophies. Neurologic Clinics, 32(3), 671–88– viii.CrossRefGoogle ScholarPubMed
Gilbreath, H. R., Castro, D. & Iannaccone, S. T., 2014. Congenital myopathies and muscular dystrophies. Neurologic Clinics.CrossRefGoogle Scholar
Ha, J. C. & Richman, D. P., 2015. Myasthenia gravis and related disorders: pathology and molecular pathogenesis. Biochimica et biophysica acta, 1852(4), 651–7.Google ScholarPubMed
Hayes, J., Veyckemans, F. & Bissonnette, B., 2008. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatric Anaesthesia, 18(2), 100–6.CrossRefGoogle ScholarPubMed
Hebl, J. R., Horlocker, T. T. & Schroeder, D. R., 2006. Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders. Anesthesia and Analgesia, 103(1), 223–8– table of contents.CrossRefGoogle ScholarPubMed
Hirsch, N. P., 2007. Neuromuscular junction in health and disease. British Journal of Anaesthesia, 99(1), 132–8.CrossRefGoogle ScholarPubMed
Hopkins, P. M., 2011. Malignant hyperthermia: pharmacology of triggering. British Journal of Anaesthesia, 107(1), 48–56.CrossRefGoogle ScholarPubMed
Jani-Acsadi, A. et al., 2015. Pediatric Charcot-Marie-Tooth Disease. Pediatric Clinics of North America, 62(3), 767–86.CrossRefGoogle ScholarPubMed
Lehmann-Horn, F., Jurkat-Rott, K. & Rüdel, R., 2002. Periodic paralysis: understanding channelopathies. Current Neurology and Neuroscience Reports, 2(1), 61–9.CrossRefGoogle ScholarPubMed
Lirk, P., Birmingham, B. & Hogan, Q., 2011. Regional anesthesia in patients with preexisting neuropathy. International Anesthesiology Clinics, 49(4), 144–65.CrossRefGoogle ScholarPubMed
Lossin, C. & George, A. L., 2008. Myotonia congenita. Advances in Genetics, 63, 25–55.CrossRefGoogle ScholarPubMed
Marchant, W. A. & Fox, R., 2002. Postoperative use of a cough-assist device in avoiding prolonged intubation. British Journal of Anaesthesia, 89(4), 644–7.CrossRefGoogle ScholarPubMed
Matthews, E. & Hanna, M. G., 2014. Repurposing of sodium channel antagonists as potential new anti-myotonic drugs. Experimental Neurology, 261, 812–15.CrossRefGoogle ScholarPubMed
McSwain, J. R., Doty, J. W. & Wilson, S. H., 2014. Regional anesthesia in patients with pre-existing neurologic disease. Current Opinion in Anaesthesiology, 27(5), 538–43.CrossRefGoogle ScholarPubMed
Mitsuhashi, S. & Kang, P. B., 2012. Update on the genetics of limb girdle muscular dystrophy. Seminars in Pediatric Neurology, 19(4), 211–18.CrossRefGoogle ScholarPubMed
Parmar, M. S. & Parmar, K. S., 2012. Emery-Dreifuss humeroperoneal muscular dystrophy: cardiac manifestations. The Canadian Journal of Cardiology, 28(4), 516.e1–3.CrossRefGoogle ScholarPubMed
Parness, J., Bandschapp, O. & Girard, T., 2009. The myotonias and susceptibility to malignant hyperthermia. Anesthesia and Analgesia, 109(4), 1054–64.CrossRefGoogle ScholarPubMed
Prior, T. W. et al., 2010. Newborn and carrier screening for spinal muscular atrophy. American Journal of Medical Genetics. Part A, 152A(7), 1608–16.CrossRefGoogle ScholarPubMed
Racca, F. et al., 2013. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders. Minerva Anestesiologica, 79(4), 419–33.Google ScholarPubMed
Schmitt, H. J. & Muenster, T., 2009. Anesthesia in patients with neuromuscular disorders. Minerva Anestesiologica, 75(11), 632–7.Google ScholarPubMed
Shipton, E. A. & Prosser, D. O., 2004. Mitochondrial myopathies and anaesthesia. European Journal of Anaesthesiology, 21(3), 173–8.CrossRefGoogle ScholarPubMed
Sieb, J. P., 2014. Myasthenia gravis: an update for the clinician. Clinical & Experimental Immunology, 175(3), 408–18.CrossRefGoogle ScholarPubMed
Snoeck, M. et al., 2015. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, pp.n/a–n/a.CrossRefGoogle Scholar
Spillane, J. et al., 2014. Myasthenia gravis – treatment of acute severe exacerbations in the intensive care unit results in a favourable long-term prognosis. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 21(1), 171–3.CrossRefGoogle Scholar
Spillane, J., Beeson, D. J. & Kullmann, D. M., 2010. Myasthenia and related disorders of the neuromuscular junction. Journal of Neurology, Neurosurgery & Psychiatry, 81(8), 850–7.CrossRefGoogle ScholarPubMed
Stowell, K. M., 2014. DNA testing for malignant hyperthermia: the reality and the dream. Anesthesia and Analgesia, 118(2), 397–406.CrossRefGoogle ScholarPubMed
The European Malignant Hyperpyrexia Group, 1984. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. British Journal of Anaesthesia, 56(11), 1267–9.Google Scholar
Van den Berg, B. et al., 2014. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews. Neurology, 10(8), 469–82.CrossRefGoogle ScholarPubMed
Van der Maarel, S. M. et al., 2012. Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation. Current Opinion in Neurology, 25(5), 614–20.CrossRefGoogle ScholarPubMed
Veyckemans, F. & Scholtes, J.-L., 2013. Myotonic dystrophies type 1 and 2: anesthetic care. Paediatric Anaesthesia, 23(9), 794–803.CrossRefGoogle ScholarPubMed
Wappler, F., 2010. Anesthesia for patients with a history of malignant hyperthermia. Current Opinion in Anaesthesiology, 23(3), 417–22.CrossRefGoogle ScholarPubMed
Weidemann, F. et al., 2015. The cardiomyopathy in Friedreich’s ataxia – New biomarker for staging cardiac involvement. International Journal of Cardiology, 194, 50–7.CrossRefGoogle ScholarPubMed
White, R. J. & Bass, S. P., 2003. Myotonic dystrophy and paediatric anaesthesia. Paediatric Anaesthesia, 13(2), 94–102.CrossRefGoogle ScholarPubMed
Wood-Allum, C. & Shaw, P. J., 2010. Motor neurone disease: a practical update on diagnosis and management. Clinical Medicine (London, England), 10(3), 252–8.Google ScholarPubMed
Worms, P. M., 2001. The epidemiology of motor neuron diseases: a review of recent studies. Journal of the Neurological Sciences, 191(1–2), 3–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×